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Abstract: Herein we report on a preparation and performance
of stable, hydrophilic and biocompatible polymeric material
suitable for functionalization of disposable substrates used in
biosensors. This new material features ACOOH surface
groups cross-linked with ethylene glycol molecules and
was prepared in situ on disposable, plastic substrate by
high-throughput and environmentally friendly technique
called plasma-enhanced chemical vapor deposition (PECVD).
The film is grafted to the plasma activated plastic by sequen-
tial deposition of tetraethylorthosilicate, forming a bonding
layer, and mixed vapors of acrylic acid and diethyleneglycol
dimethylether (AA/PEG) that provide the desired functional
groups forming a sensing, contact layer. A superior perform-
ance of the AA/PEG coating as suitable material for sub-
strates in biomedical devices was demonstrated in a model
fluorescence linked immunosorbent assay. The results were
compared with other commonly used surface materials pre-
pared by wet chemistry methods. The unique characteristic
of the AA/PEG film is that the immunoassay can be executed
without the need for a blocking step, typically using albu-
mins, without negative consequences on the bioassay
results. In fact, the superior quality of the materials modified
with AA/PEG film was highlighted by improving the sensitiv-
ity of an immunoassay by two orders of magnitude when
compared with substrates prepared by standard surface
chemistry methods. VC 2011 Wiley Periodicals, Inc. J Biomed Mater
Res Part A: 100A: 230–235, 2012.
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INTRODUCTION
In biomedical diagnostics, the chemical composition of the
substrate surface and the subsequent cell or protein/surface
interactions are considered to be the crucial factors defining
the background response and effectively controlling the sen-
sitivity of the device. In a successful bioassay device, it is
absolutely critical to reduce the nonspecific binding (NSB)
of the detection molecules in the absence of the target ana-
lyte, thus eliminate ‘false positive’ results. Therefore, surface
coatings that can be mass-produced and combine the qual-
ity of low nonspecific binding and simultaneously have the
ability to covalently immobilize biomaterial are of particular
interest in biosensor applications. Poly- (ethylene glycol)
(PEG) in different forms has proven to be a suitable mate-
rial for construction of protein-resistant biosensor surfa-
ces.1–4 The low NSB function of PEG-molecules is associated
with vast hydration and effects of change in configurational
entropy when large molecules adsorb upon them. A number
of reports describe the preparation of films with crosslinked
and noncrosslinked PEG-based matrixes by wet chemistry
or vapor methods.5–13 The latter is of great interest for
industrial mass production processes. We have carried out
extensive research in Plasma Enhanced Chemical Vapour
Deposition (PECVD) of a wide spectrum of biofunctional
films with silica-like,5 amino,14,15 and carboxylic1 functional
groups on cyclo olefin polymer (COP) substrates. ZeonorVR , a
type of COP is characterized by ease of fabrication of bioas-
say chips with complex microfluidics and relatively low
autofluorescence, which is an important factor for fluores-
cence-based applications. The chemical contrasts in surfaces
produced in our group were fabricated by functionalizing
ZeonorVR with various organosilanes as illustrated on
Figure 1. However, the major limitation to this technique is
the availability of organosilanes precursors with suitable
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vapor pressure. Therefore, the development of alternative
routes to functionalize plastic material for bioassay devices
remains of great importance.
Here we present a generic method using tetraorthosilicate
(TEOS) as a siloxane-containing precursor to form a bonding
layer with the substrate, onto which acrylate (further in the
text referred as AA film) or methacrylate monomers together
with a short PEG derivative, diethylene glycol dimethyl ether
(DEGDME) could be sequentially grafted (Fig. 1). The function
of the PEG precursor is to act as a protein-resistant coreac-
tant.1,3,5,13,16 Exposure of the plastic substrate to evaporating
TEOS followed by vapors containing a mixture of molecules of
DEGDME and acrylic acid produced a stable film containing
both the reactive carboxylic acid groups and repellent PEG-like
groups (further in the text referred as AA/PEG film). Once
activated, the available ACOOH groups could be used to cova-
lently immobilize biorecognition elements like antibodies. The
protein resistant PEG functionality on the other hand, should
contribute to the reduction of the nonspecific binding of the
nonanalyte constituents of the sample. The expected net effect
is an improved signal-to-noise ratio. Therefore, the central
objective of this communication is to demonstrate the quality
of such surface with embedded ACOOH–PEG–like functionality
in a model sandwich immunoassay. The efficiency of the
PECVD prepared coating to reduce NSB was compared with
several other films, frequently used in bioassays. A human IgG,
fluorescence linked immunosorbent assay was performed with
selected surfaces to show how increase in signal/noise ratio
directly translates into improvements in assay sensitivity.
MATERIALS AND METHODS
Surface chemistry
Wet chemistry methods. Plain COP slides (Zeonor
VR
1060R)
75 mm  25 mm were obtained from Sigolis AB (Uppsala,
Sweden), 3  3 parabola element biochip was injection
molded in Zeonex
VR
copolymer (Nalux, Japan). All substrates
were oxidized in oxygen plasma. The plasma oxidation of
the material took place during 1 min at 200 mTorr, 200 W
and with a flow of oxygen at 100 mL/min, in expanded
plasma cleaner (PDC- 002, Harrick Science, Ossing, NY).
PDITC coating. After plasma oxidation, the 3  3 parabola
element biochip as well as 2.5  7.5 cm2 COP slides were
immersed in a solution of 3 vol % 3-Aminopropyltriethoxy-
silane (APTES, Fluka) in 95% ethanol for 2 h, similar to the
process used for glass surfaces.5
For reaction with PDITC, the APTES-modified COP sub-
strates were immersed in a 25 mM PDITC in DMF:pyridine
(9:1, v/v) solution for 2 h. The slides were then rinsed with
DMF and MeOH and dried under a stream of nitrogen.
Oxidized dextran coating. APTES coated chips were
immersed in an oxidized 2% dextran solution (Dextran T40
(40 kDa), Pharmacosmos, Denmark) for 2 h,1 rinsed in
MilliQ-H2O and further oxidized in 30 mM NaIO4 (Sigma
Aldrich) for 2 h.
PECVD method. The deposition of ACOOH and ACOOH/
DEGDME functional coatings was carried out in a computer
controlled PECVD reactor Europlasma, model CD300 (Oude-
naarde, Ghent, Belgium). An aluminum vacuum chamber,
connected to a Dressler CESAR 136 RF power source (Mun-
sterau, Stolberg, Germany) with an operating frequency of
13.56 MHz, with an automated impedance-matching box,
was used. The details of the deposition system is provided
elsewhere.17 TEOS, AA, and diethylene glycol dimethyl ether
were contained in three separate single side blocked KF16
nipples (Kurt J Lesker, UK) connected to the chamber indi-
vidually through needle valves. The needle valves were used
to control the sequential flow of vapors of tetraethylorthosi-
licate (TEOS) and acrylic acid (AA) for AA coating and a
mixture of vapors of acrylic acid and diethylene glycol
FIGURE 1. A schematic illustration of the in-situ PECVD process. COP substrates are oxidized in a plasma reactor and subsequently exposed to
vapors of organosilanes that polymerize to form films with ASH, ANH2, or ACOOH functionality. Alternatively, tetraorthosilicate is deposited to
form the bonding layer, onto which mixture of precursors such as acrylic acid (AA) and diethylene glycol dimethylether (PEG) are grafted.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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dimethyl ether for AA/PEG film. Plasma pretreatment was
carried out at an RF power of 250 Watts for 3 min with
50 sccm of argon flow and 50 sccm of oxygen flow. The
plasma deposition was carried out in argon plasma. Plasma
pretreatment, deposition of TEOS and AA/PEG were all
carried out sequentially.
Fluorescence linked immunosorbent assay
Human IgG from serum, goat anti-human IgG (Fab specific)
and bovine serum albumin (BSA) were purchased from
Sigma (St. Louis, MO). Alexa Fluor 647 labeled goat anti-
human IgG was purchased from Molecular Probes
TM
(Eugene, OR). Capture antibody (goat anti-human IgG) was
immobilized on each surface by incubation of a solution of
400 lg/mL in Phosphate buffered saline (PBS) containing
1% v/v Tween 20 on the surface in a humid chamber at
37C for 1 h. For covalent immobilization of antibodies on
the AA and AA/PEG films, the ACOOH surface groups were
activated by immersing the substrates into 100 mM aqueous
solution of 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide
Hydrochloride (EDC) and 100 mM of N-hydroxysiccinimide
(NHS) for 10 min. The slides were then rinsed one time
with MilliQ water and 1–3 lL droplets of goat anti-human
IgG at a concentration of 400 lg/mL were transferred on to
the activated surface and incubated at 37C for 1 h. The
slides were then rinsed with a PBS solution containing
Tween 20 (1%, v/v) for 10 min, followed by 5-min rinse
with MilliQ water and dried with a stream of nitrogen. For
all measured surfaces, except for AA/PEG this was followed
by a blocking step of incubation of a solution of 1% w/v
BSA in PBS Tween for 1 h at room temperature. For assay
measurements, IgG sample solutions were prepared by
diluting IgG in PBS Tween solution. Eight concentrations
were prepared by diluting in steps of ten (100,000, 10,000,
1000, 100, 10, 1, 0.1, 0.01 ng/mL). Plain PBS buffer was
used as a negative control and also to assess the level of
nonspecific binding (0 ng/mL). Chips and slides were
washed for 10 min in PBS Tween followed by 5 min in DI
water and were blown dry with nitrogen. Finally, labeled
antibody (Alexa fluor 648-labeled goat anti-human IgG) was
added at a concentration of 200 lg/mL in PBS Tween and
was incubated for 1 h at 37C. In all cases, a volume of
1 lL was used for the 3  3 parabola element biochip and
a volume of 3 lL was used for the microscope size slides.
The fluorescence signal of the COP slides was recorded on
PerkinElmer ScanArray Express (PerkinElmer, MA) with
laser excitation wavelength of 633 nm and emission filter
wavelength of 670 nm. The fluorescence signal of the 3 x 3
parabola element biochips was measured as described
below.
Supercritical angle fluorescence measurement
The 3  3 parabola element biochip is shown pictorially
and schematically in Figure 2. The chip is designed to be
illuminated from below in an optics system discussed previ-
ously.7 This system allows for total internal reflection
fluorescence (TIRF) excitation and supercritical angle fluo-
rescence (SAF) detection giving it a high surface specificity.
Briefly, a laser beam is expanded to illuminate all nine
parabolas simultaneously. Light couples to the top surface
of the parabola and fluorophores at the surface are excited
via the evanescent wave. These surface-bound fluorophores
then emit much of their light at high angles (larger than the
critical angle) causing it to typically be trapped inside the
substrate. The shape of the parabola element is designed to
recover this light as shown schematically in Figure 2. An
annular aperture is used to ensure that only light from sur-
face-bound fluorophores is collected and imaged by the CCD
FIGURE 2. The parabolic chip used is shown (a) pictorially and (b) schematically. Collected images of background levels from an unwashed
chip coated with (c) PDITC and (d) AA/PEG are shown with the same gain setting. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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camera producing the images shown in Figure 2(c,d). Fluo-
rescence intensities were calculated by measuring the sum
of the light in the ring created by each parabolic SAF collec-
tion element using Matlab image processing.
RESULTS AND DISCUSSION
Surface chemistry
The functionalization of plastic substrates, such as COP, for
bioassay applications has recently attracted lots of scientific
and technological interest. Surface functionalization of COP
carried out by wet chemistry methods is relatively well
known. To our best knowledge, the two methods we have
chosen to coat the plastic surface are currently being
explored for the use in commercial bioassay devices.18
Material modified with 1,4-phenyldiisothiocyanate (PDITC)
surface is also commercially available.6 The surface modifi-
cation by wet chemistry requires a two-step process, in
which large amount of solvent is used. The first step
involves silanization of the plastic substrate, using (3-amino-
propyl)dimethylethoxysilane (APTES), to create an adhesive
layer on oxidized COP. The resultant amino terminated sur-
face is subsequently functionalized with either a dextran
matrix or PDITC cross-linker, which allows for immobiliza-
tion of capture antibodies. On the other hand, the PECVD
process represents a straightforward, industrially scalable,
one step, in-situ and solvent-free method. As seen in Table I,
treatment of the COP by PECVD techniques as well as by
oxidized dextran (oxid. dextran) renders the surface hydro-
philic, which is in contrast to the PDITC film. The film
thicknesses of various films are also given in Table I. The
apparent higher error variations in the thickness of the
PECVD prepared surfaces are attributed to a very specific
deposition approach, as illustrated on Figure 1. The reaction
mechanism involves an activation of the substrate with
high-energy plasma, followed by deposition of partially frag-
mented precursor vapors under low-energy plasma. How-
ever, it is necessary put this into a perspective with the size
of the antibodies that are immobilized on such surface. If
the antibody footprint is considered to be 100 nm2, the
error values of 1.4 or 0.7 nm for the PECVD films are con-
sidered almost negligible. Overall, we reason that the
capacity of AA/PEG film to reduce nonspecific adsorption of
proteins is due to a proper combination of various factors
such as the changes in surface potential polarity, adhesion
force, effects of swelling in buffered solution and ‘‘hardness’’
of the surface.
Nonspecific binding measurements on supercritical
angle fluorescence system
To compare the effect of nonspecific adsorption on the pre-
pared surfaces, we used an in-house designed detection
TABLE I. Water Contact Angles and Thickness of Coatings





Pristine COP 92.35 6 1.55 –
Wet chemistry
methods
APTES 55.05 6 2.60 13.39 6 0.48
PDITC 70.43 6 1.26 15.21 6 0.22
Oxid. dextran 30.19 6 0.28 15.23 6 0.10
PECVD AA 9.85 6 0.21 5.70 6 1.40
AA/PEG 18.41 6 0.96 5.59 6 0.70
FIGURE 3. Top—The fluorescence signal of the labeled, detection
antibodies, presented as nonspecific binding was measured at zero
concentration of the analyte. The degree of binding of the detection
molecules to the surface in the absence of the analyte controls the
background response and hence the sensitivity of an assay. Bottom—
a cartoon representation illustrating the design of the experiments on
washed (a), unwashed (b), and unwashed-BSA blocked (c) 3  3
parabola element biochips. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Relative nonspecific binding, presented as an increment of
fluorescence signal change of studied coatings relative to fluores-
cence signal of AA/PEG surface. The fluorescence of labeled detection
antibodies was measured on unwashed 3  3 parabola element
biochips at zero concentration of analyte. The experiment design is
also illustrated in Figure 3(A).
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system based on Supercritical Angle Fluorescence (SAF).7
The principle is illustrated in Figure 2. The biochip is made
of injection molded COP with nine parabolic elements
that allow for surface specific fluorescence collection. The
discrimination of the bulk fluorescence prompted us to
investigate the ability to measure ‘‘unwashed’’ samples, as
illustrated in Figure 3(B). Under this experimental setup,
the fluorescently labeled detection molecules would be
specifically bound to the analytes in the typical sandwich
format, with large excess of unbound labeled molecules in
the bulk solution. Because it is desirable to prevent binding
of the detection molecules to the surface in the absence of
the target analyte (in order to eliminate ‘‘false positive’’
results), it is a good practice to block the surface after the
immobilization of capture antibodies with blocking reagent,
such as BSA. While the fluorescence intensities from AA,
BSA blocked AA, and AA/PEG coated chips were already
reasonably low, washing the excess of the bulk detection
antibody further decreased the background fluorescence
signal of up to four times. The effect of BSA to prevent non-
specific binding of proteins is evident in both Figures 3 and 4.
Figure 4 shows an increment of fluorescence signal change
measured on unwashed chips functionalized with wet
chemistry methods relative to that of AA/PEG. In this light,
the AA/PEG surface compared favorably with all other
surfaces. Only biochips with BSA blocked AA and oxidized
dextran films showed lower background response than
AA/PEG chemistry (although with no BSA blocking step).
The oxidized dextran coating also showed reduction in
binding levels when blocked with BSA, which is attributed
to the polar nature of the polysaccharide and high degree
of hydration. However, in the absence of BSA, it also
showed relatively high variations between the spots and
poor uniformity.
Fluorescence linked immunosorbent assay
The immunoassay was carried out by immobilization
of goat-anti-human IgG on both the PDITC and AA/PEG
modified COP slides. The analyte, human IgG, was then
allowed to react with the surface captured antibody and the
amount of analyte was detected by reaction with Alexa
648-goat-anti-human IgG antibody. The concentrations of
the capture and detection antibodies were optimized to
0.4 and 0.2 mg/mL, respectively. The PDITC surface was
blocked with 1% w/v solution of BSA after the immobiliza-
tion of captured antibody, while the AA/PEG surface was
used without the extra blocking step. These optimal values
were then used for the immunoassay. The limit of detection
(LOD) for PDITC surface was calculated to be 36.9 ng/mL.
The value for the AA/PEG surface was determined to be
0.11 ng/mL, showing an improvement by two orders of
magnitude. The LOD was calculated as concentration that
corresponds to the background signal plus three times the
standard deviation of the background signal. Theses values
are of similar order to the LODs obtained for immunoassays
on other PDITC coated COP, silicon or glass substrates.8–11
Because of significantly lower background signal on the
AA/PEG slide, not even blocked by BSA, the LOD improved
by two orders of magnitude and the maximum fluorescence
Fmax/F0 was more than 35 times better on the PECVD
coated substrate than the one prepared by standard
PDITC surface chemistry. This effectively demonstrates the
superior properties of AA/PEG coating in a model sandwich
immunoassay.
CONCLUSION
In this work, carboxylic-functionalized film in a matrix of
protein-resistant PEG was fabricated on cyclo olefin poly-
mer. Such a film with its highly reactive carboxy sites
enabled covalent attachment of biomolecules on the surface,
while its low reactivity PEG sites prevented the nonspecific
binding of other nonanalyte solution constituents. The
surface capacity of suppressing background fluorescence
was demonstrated on a prototype of biochip device based
on supercritical angle fluorescence detection. A model
immunosorbent assay was performed to illustrate how
FIGURE 5. Human IgG immunoassay curves for unblocked AA/PEG (blue curve) modified surface and BSA blocked PDITC (red curve) modified
COP slides. Inset shows the region of the calculated limit of detection for both surfaces. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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reduction in background response translates into improve-
ments in signal-to-noise ratio and subsequently to improved
limit of detection. The sensitivity improved by two orders of
magnitude as a direct consequence of the optimal surface
chemistry. The effect of the carboxy coating with incorporated
PEG matrix was compared with other films prepared by either
wet chemistry methods or plasma-assisted vapor technique.
The results suggest that the PECVD process of codepositing
reactive carboxylic functionality and repellant PEG functional-
ity is indeed capable of preparing surfaces for mass industrial
production, characteristics of which are comparable or even
better to those that are frequently used in immunoassays by
other scientific and industrial entities.
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